Fludarabine
Enteropathy Associated T-cell Lymphoma
National Cancer Institute (NCI)Small moleculePhase 1Active
CC
47/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 32/ 100
- Competitive Position
- 95/ 100
Competitive context
20 Active assets in the Enteropathy Associated T-cell Lymphoma cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Inno-206 Eric Jacobsen, MD | Phase 4 | BBB |
ETOPOSIDE Eric Jacobsen, MD | Phase 4 | BBB |
Cyclophosphamide National Cancer Institute (NCI) | Phase 4 | BBB |
PREDNISONE TABLETS Eric Jacobsen, MD | Phase 4 | BB |
Ifosfamide Shandong Provincial Hospital | Phase 4 | BB |
View all 36 →
Same molecule, other indications
Fludarabine is also rated in:
acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22)Dormant
BBB
Indicative ·
76 / 100
View asset →Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →